Healthcare

This function is exclusive for Premium subscribers

  • DATABASE (359)

  • ARTICLES (108)

    • DATABASE (359)
    • ARTICLES (108)

New Ventures has over the past decade focused on growing and catalyzing social and environmental entrepreneurs. They build an ecosystem through financing, acceleration, and promotion. In doing so, they pave the way for enterprises that are not only profitable but have a positive impact on social and environmental issues.

Founded in 2010, Runa Capital is an early-stage VC that invests across North America, Asia and Europe. It manages funds worth US$270m and has invested in more than 40 companies, primarily in the healthcare, fintech, B2B SaaS and education sectors. The firm invested in Capptain, an app management platform acquired by Microsoft in 2014.

Mustard Seed MAZE is a Lisbon-based VC firm that invests in early-stage startups, primarily in social impact enterprises. Endowed with €40m, the VC has invested in projects dealing with food wastage, human trafficking, postnatal depression and general healthcare.So far, it has managed one exit, with the majority of its portfolio of 20 companies based in Europe. Recent investment rounds include $3m seed funding for Portuguese mesh network tech HypeLabs, €1.15m seed round for Spanish fintech StudentFinance and $12m Series B round for UK-based food waste app Winnow.

Founded in 2015, Hovione Capital is a VC firm from Portugal specializing in the health sector, with a focus on seed/early-stage investments in healthcare and medtech businesses. It currently manages €5 million in investment assets across its portfolio of three companies.

KTB Network is a leading investment firm in South Korea, conducting investments across all stages in South Korea, China and the US. KTB Network is the first South Korean investment firm to enter the Chinese PE/VC market. Since 2000, it has invested in 40+ companies in China.

Founded in 2014, River VC focuses on early-stage investment in startups in the internet, consumer, smart hardware and big health sectors. 

Established in Shanghai in 2014, Wuqiong Venture Capital is an early-stage investment firm, having backed more than 10 startups in China including Beautysite, CeCelife and Orange-social.

Established in 2011, PE firm Sharelink Capital manages assets of more than RMB 1.5 billion and has invested in nearly 40 enterprises.It focuses on early-stage and mid-stage investments. Its investors include the National Science and Technology Department, large state-owned enterprises, local governments, listed companies, private enterprises and high net worth individuals.

Yifuze Investment was founded in 2010 by renowned trader and investor Lin Guangmao. Lin made his name trading cotton futures that year, turning RMB 30,000 worth of contracts into a RMB 2 billion fortune.

Pathena is a Porto-based venture capital firm founded in 2010 and focuses on IT investments, particularly medtech. Pathena closed its first portfolio fund in 2011, having invested in 10 companies and it launched its current portfolio fund in 2013 worth €56 million.

The Woodford Patient Capital Trust is part of the larger group Woodford Funds. The company is based in Oxford and was formed in 2014, headed by veteran fund manager Neil Woodford. The Patient Capital Trust focuses on early- and early-growth-stage companies, with target returns of more than 10% yearly. The bulk of their portfolio comprises healthcare companies. 

Vangoo Capital Partners was founded in 2008 in Hongkong as a wholly owned subsidiary of Ant Capital Partners. Ant Capital Partners completed localization in China by finishing management buy-out of Vangoo Capital Partners in 2011. Vangoo Capital Partners manages both US$ Fund and RMB funds. It focuses on the investment of medical, Internet, consumer products, high-tech, and new energy.

Creadev was created in 2002 in France as the private equity arm of the Mulliez family. Creadev expanded to Shanghai in 2012, through a unit called Crehol China. It has since been renamed Creadev China.  

CRCM Ventures is a unit of US- and HK-listed ChinaRock Capital Management. Headquartered in San Francisco with branch offices in Palo Alto, Beijing and Hong Kong, CRCM Ventures invests in seed and early-stage Silicon Valley and China technology startups, with more than 20 years of experience in public and private investing.

Founded in 2007 under the Chinese Fortune 500 company DunAn Group, the investment group manages total fund of RMB 6 billion today, with successful investment in 77 Chinese startups across multiple sectors including healthcare, advanced manufacturing, energy & cleantech, etc. It was nominated for “Top 10 Zhengjiang Investment Group” for seven years in a row and was awarded for “Chinese VC of Best Potential” in 2016 – 2017 by thecapital.com.cn.  

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.